Relationship between MDR1 polymorphism and blood concentration of cyclosporine A

Chinese Medical Journal

Volumn 118, Issue 24, 2005, Pages 2097-2100

  Wang, Wei ^a   Zhang, Xiao Dong ^a   Guan, De Lin ^b   Lü, Yue Ping ^a,b   Ma, Lin Lin ^a,b   Hu, Xiao Peng ^a,b   Zhang, Peng ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

Cyclosporine A; Kidney transplantation; Multidrug resistance gene 1; P glycoprotein; Polymorphism

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MULTIDRUG RESISTANCE PROTEIN 1; PREDNISONE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; DRUG BLOOD LEVEL; EXON; GENOTYPE; GRAFT RECIPIENT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MAJOR CLINICAL STUDY; PROTEIN POLYMORPHISM; BLOOD; FEMALE; GENE; GENETIC POLYMORPHISM; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; CYCLOSPORINE; FEMALE; GENES, MDR; GENOTYPE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 33644859568     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chen C, Clark D, Ueda K, et al. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem 1990;265:506-514.
2. Benet LZ, Izumi T, Zhang Y, et al. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. J Control Release 1999;62:25-31.
3. Kim RB, Leake BF, Choo EF, et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 2001;70:189-199.
4. Cascorbi I, Gerloff T, Johne A, et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 2001;69:168-174.
5. Arceci RJ. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 1993;81:2215-2222.
6. Van Helvoort A, Smith AJ, Sprong H, et al. MDR1 P-glycoprotein is a lipid translocase of broad specificity,while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 1996;87:507-517.
7. Cooper DN, Smith BA, Cooke HJ, et al. An estimate of unique DNA sequence heterozygosity in the human genome. Hum Genet 1985;69:201-205.
8. Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000;97:3473-3478.
9. + natural killer cells. Pharmacogenetics 2001;11:293-298.
10. Tanabe M, Ieiri I, Nagata N, et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 2001;297:1137-1143.
11. Verstuyft C, Strabach S, Morabet HE, et al. Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition. Clin Pharmacol Ther 2003;73:51-60.
12. Balram C, Sharma A, Sivathasan C, et al. Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates. J Clin Pharmacol 2003;56:78-83.
13. Ameyaw MM, Regateiro F, Liu T, et al. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 2001;11:217-221.
14. Isaacs RB, Lobo PI, Nock SL, et al. Racial disparities in access to simultaneous pancreas-kidney transplantation in the United States. Am J Kidney Dis 2000;36:526-533.
15. Koyama H, Cecka JM, Terasaki PI. Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival. Transplantation 1994;57:1064-1068.